CheckMate 025: a randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC)

Robert J. Motzer; Bernard Escudier; David F. Mcdermott; Saby George; Hans J. Hammers; Sandhya Srinivas; Scott S. Tykodi; Jeffrey A. Sosman; Giuseppe Procopio; Elizabeth R. Plimack; Daniel Castellano; Howard Gurney; Frede Donskov; Petri Bono; John Wagstaff; Thomas C. Gauler; Takeshi Ueda; Li-An Xu; Ian M. Waxman; Padmanee Sharma; CheckMate 025 Investigators

CheckMate 025: a randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC)

Robert J. Motzer, Bernard Escudier, David F. Mcdermott, Saby George, Hans J. Hammers, Sandhya Srinivas, Scott S. Tykodi, Jeffrey A. Sosman, Giuseppe Procopio, Elizabeth R. Plimack, Daniel Castellano, Howard Gurney, Frede Donskov, Petri Bono, John Wagstaff, Thomas C. Gauler, Takeshi Ueda, Li-An Xu, Ian M. Waxman, Padmanee Sharma CheckMate 025 Investigators

Research output: Contribution to journal › Meeting abstract

15 Citations (Scopus)

Original language	English
Pages (from-to)	17
Number of pages	1
Journal	BJU international
Volume	116
Issue number	S5
Publication status	Published - Dec 2015
Externally published	Yes
Event	14th International Kidney Cancer Symposium - Miami Duration: 6 Nov 2015 → 7 Nov 2015

Cite this

Motzer, R. J., Escudier, B., Mcdermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., Castellano, D., Gurney, H., Donskov, F., Bono, P., Wagstaff, J., Gauler, T. C., Ueda, T., Xu, L-A., Waxman, I. M., ... CheckMate 025 Investigators (2015). CheckMate 025: a randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC). BJU international, 116(S5), 17.

@article{09bc5c9382f045a0ba3c4d5031a353a2,

title = "CheckMate 025: a randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC)",

author = "Motzer, {Robert J.} and Bernard Escudier and Mcdermott, {David F.} and Saby George and Hammers, {Hans J.} and Sandhya Srinivas and Tykodi, {Scott S.} and Sosman, {Jeffrey A.} and Giuseppe Procopio and Plimack, {Elizabeth R.} and Daniel Castellano and Howard Gurney and Frede Donskov and Petri Bono and John Wagstaff and Gauler, {Thomas C.} and Takeshi Ueda and Li-An Xu and Waxman, {Ian M.} and Padmanee Sharma and {CheckMate 025 Investigators}",

year = "2015",

month = dec,

language = "English",

volume = "116",

pages = "17",

journal = "BJU international",

issn = "1464-4096",

publisher = "Wiley-Blackwell, Wiley",

number = "S5",

note = "14th International Kidney Cancer Symposium ; Conference date: 06-11-2015 Through 07-11-2015",

}

Motzer, RJ, Escudier, B, Mcdermott, DF, George, S, Hammers, HJ, Srinivas, S, Tykodi, SS, Sosman, JA, Procopio, G, Plimack, ER, Castellano, D, Gurney, H, Donskov, F, Bono, P, Wagstaff, J, Gauler, TC, Ueda, T, Xu, L-A, Waxman, IM, Sharma, P & CheckMate 025 Investigators 2015, 'CheckMate 025: a randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC)', BJU international, vol. 116, no. S5, pp. 17.

TY - JOUR

T1 - CheckMate 025

T2 - 14th International Kidney Cancer Symposium

AU - Motzer, Robert J.

AU - Escudier, Bernard

AU - Mcdermott, David F.

AU - George, Saby

AU - Hammers, Hans J.

AU - Srinivas, Sandhya

AU - Tykodi, Scott S.

AU - Sosman, Jeffrey A.

AU - Procopio, Giuseppe

AU - Plimack, Elizabeth R.

AU - Castellano, Daniel

AU - Gurney, Howard

AU - Donskov, Frede

AU - Bono, Petri

AU - Wagstaff, John

AU - Gauler, Thomas C.

AU - Ueda, Takeshi

AU - Xu, Li-An

AU - Waxman, Ian M.

AU - Sharma, Padmanee

AU - CheckMate 025 Investigators

PY - 2015/12

Y1 - 2015/12

UR - https://doi.org/10.1111/bju.13365

M3 - Meeting abstract

C2 - 26492557

SN - 1464-4096

VL - 116

SP - 17

JO - BJU international

JF - BJU international

IS - S5

Y2 - 6 November 2015 through 7 November 2015

ER -

CheckMate 025: a randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC)

Other files and links

Cite this